Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Endotoxin regulates matrix genes increasing reactive oxygen species generation by intercellular communication between palmitate-treated hepatocyte and stellate cell.

Dornas W, Glaise D, Bodin A, Sharanek A, Burban A, Le Guillou D, Robert S, Dutertre S, Aninat C, Corlu A, Lagente V.

J Cell Physiol. 2018 Jan;234(1):122-133. doi: 10.1002/jcp.27175. Epub 2018 Sep 7.

PMID:
30191979
2.

The rs3957357C>T SNP in GSTA1 Is Associated with a Higher Risk of Occurrence of Hepatocellular Carcinoma in European Individuals.

Akhdar H, El Shamieh S, Musso O, Désert R, Joumaa W, Guyader D, Aninat C, Corlu A, Morel F.

PLoS One. 2016 Dec 9;11(12):e0167543. doi: 10.1371/journal.pone.0167543. eCollection 2016.

3.

Reply: The Impact of Septic Liver Dysfunction on Long-Term Mortality Must Not Be Neglected.

Nesseler N, Launey Y, Aninat C, White J, Corlu A, Pieper K, Mallédant Y, Seguin P.

Am J Respir Crit Care Med. 2016 May 15;193(10):1184. doi: 10.1164/rccm.201602-0401LE. No abstract available.

PMID:
27174485
4.

Liver Dysfunction Is Associated with Long-Term Mortality in Septic Shock.

Nesseler N, Launey Y, Aninat C, White J, Corlu A, Pieper K, Mallédant Y, Seguin P.

Am J Respir Crit Care Med. 2016 Feb 1;193(3):335-7. doi: 10.1164/rccm.201508-1660LE. No abstract available.

PMID:
26829424
5.

Glutathione transferases P1/P2 regulate the timing of signaling pathway activations and cell cycle progression during mouse liver regeneration.

Pajaud J, Ribault C, Ben Mosbah I, Rauch C, Henderson C, Bellaud P, Aninat C, Loyer P, Morel F, Corlu A.

Cell Death Dis. 2015 Jan 15;6:e1598. doi: 10.1038/cddis.2014.562.

6.

Inflammatory cytokines promote the retrodifferentiation of tumor-derived hepatocyte-like cells to progenitor cells.

Dubois-Pot-Schneider H, Fekir K, Coulouarn C, Glaise D, Aninat C, Jarnouen K, Le Guével R, Kubo T, Ishida S, Morel F, Corlu A.

Hepatology. 2014 Dec;60(6):2077-90. doi: 10.1002/hep.27353. Epub 2014 Oct 29.

PMID:
25098666
7.

Clinical review: The liver in sepsis.

Nesseler N, Launey Y, Aninat C, Morel F, Mallédant Y, Seguin P.

Crit Care. 2012 Oct 30;16(5):235. doi: 10.1186/cc11381. Review.

8.

Regulation of signal transduction by glutathione transferases.

Pajaud J, Kumar S, Rauch C, Morel F, Aninat C.

Int J Hepatol. 2012;2012:137676. doi: 10.1155/2012/137676. Epub 2012 Oct 9.

9.

Investigation of ifosfamide nephrotoxicity induced in a liver-kidney co-culture biochip.

Choucha-Snouber L, Aninat C, Grsicom L, Madalinski G, Brochot C, Poleni PE, Razan F, Guillouzo CG, Legallais C, Corlu A, Leclerc E.

Biotechnol Bioeng. 2013 Feb;110(2):597-608. doi: 10.1002/bit.24707. Epub 2012 Aug 28.

PMID:
22887128
10.

Predictive toxicology using systemic biology and liver microfluidic "on chip" approaches: application to acetaminophen injury.

Prot JM, Bunescu A, Elena-Herrmann B, Aninat C, Snouber LC, Griscom L, Razan F, Bois FY, Legallais C, Brochot C, Corlu A, Dumas ME, Leclerc E.

Toxicol Appl Pharmacol. 2012 Mar 15;259(3):270-80. doi: 10.1016/j.taap.2011.12.017. Epub 2011 Dec 24.

11.

The glutathione transferase kappa family.

Morel F, Aninat C.

Drug Metab Rev. 2011 May;43(2):281-91. doi: 10.3109/03602532.2011.556122. Epub 2011 Mar 23. Review.

PMID:
21428694
12.

Improvement of HepG2/C3a cell functions in a microfluidic biochip.

Prot JM, Aninat C, Griscom L, Razan F, Brochot C, Guillouzo CG, Legallais C, Corlu A, Leclerc E.

Biotechnol Bioeng. 2011 Jul;108(7):1704-15. doi: 10.1002/bit.23104. Epub 2011 Mar 11.

PMID:
21337338
13.

Differential toxicity of heterocyclic aromatic amines and their mixture in metabolically competent HepaRG cells.

Dumont J, Jossé R, Lambert C, Anthérieu S, Le Hegarat L, Aninat C, Robin MA, Guguen-Guillouzo C, Guillouzo A.

Toxicol Appl Pharmacol. 2010 Jun 1;245(2):256-63. doi: 10.1016/j.taap.2010.03.008. Epub 2010 Mar 20.

PMID:
20307560
14.

Anticancer drug 5-fluorouracil induces reproductive and developmental defects in Caenorhabditis elegans.

Kumar S, Aninat C, Michaux G, Morel F.

Reprod Toxicol. 2010 Jul;29(4):415-20. doi: 10.1016/j.reprotox.2010.02.006. Epub 2010 Mar 4.

PMID:
20206682
15.

Drug-metabolising enzymes are down-regulated by hypoxia in differentiated human hepatoma HepaRG cells: HIF-1alpha involvement in CYP3A4 repression.

Legendre C, Hori T, Loyer P, Aninat C, Ishida S, Glaise D, Lucas-Clerc C, Boudjema K, Guguen-Guillouzo C, Corlu A, Morel F.

Eur J Cancer. 2009 Nov;45(16):2882-92. doi: 10.1016/j.ejca.2009.07.010. Epub 2009 Aug 18.

PMID:
19695866
16.

Intramolecular hydrogen bonding as a determinant of the inhibitory potency of N-unsubstituted imidazole derivatives towards mammalian hemoproteins.

Perrin L, André F, Aninat C, Ricoux R, Mahy JP, Shangguan N, Joullié MM, Delaforge M.

Metallomics. 2009 Mar;1(2):148-56. doi: 10.1039/b817743k. Epub 2008 Nov 27.

PMID:
21305108
17.

Metabolism of phenylahistin enantiomers by cytochromes P450: a possible explanation for their different cytotoxicity.

Perrin L, Aninat C, Hamon V, Hayashi Y, Abadie C, Heyd B, André F, Delaforge M.

Drug Metab Dispos. 2008 Nov;36(11):2381-92. doi: 10.1124/dmd.107.019919. Epub 2008 Aug 7.

PMID:
18687804
18.

Catecholamines induce an inflammatory response in human hepatocytes.

Aninat C, Seguin P, Descheemaeker PN, Morel F, Malledant Y, Guillouzo A.

Crit Care Med. 2008 Mar;36(3):848-54. doi: 10.1097/CCM.0B013E31816532BE.

PMID:
18431272
19.

Long-term functional stability of human HepaRG hepatocytes and use for chronic toxicity and genotoxicity studies.

Jossé R, Aninat C, Glaise D, Dumont J, Fessard V, Morel F, Poul JM, Guguen-Guillouzo C, Guillouzo A.

Drug Metab Dispos. 2008 Jun;36(6):1111-8. doi: 10.1124/dmd.107.019901. Epub 2008 Mar 17.

PMID:
18347083
20.

The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics.

Guillouzo A, Corlu A, Aninat C, Glaise D, Morel F, Guguen-Guillouzo C.

Chem Biol Interact. 2007 May 20;168(1):66-73. Epub 2006 Dec 16. Review.

PMID:
17241619
21.

Potent inhibition of carcinogen-bioactivating cytochrome P450 1B1 by the p53 inhibitor pifithrin alpha.

Sparfel L, Van Grevenynghe J, Le Vee M, Aninat C, Fardel O.

Carcinogenesis. 2006 Mar;27(3):656-63. Epub 2005 Oct 29.

PMID:
16258175
22.

Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells.

Aninat C, Piton A, Glaise D, Le Charpentier T, Langouët S, Morel F, Guguen-Guillouzo C, Guillouzo A.

Drug Metab Dispos. 2006 Jan;34(1):75-83. Epub 2005 Oct 4.

PMID:
16204462
23.

Oxidative metabolism by P450 and function coupling to efflux systems: modulation of mycotoxin toxicity.

Aninat C, André F, Delaforge M.

Food Addit Contam. 2005 Apr;22(4):361-8. Review.

PMID:
16019806
24.

Inhibitory effects of roquefortine on hepatic cytochromes P450.

Aninat C, Delaforge M.

Adv Exp Med Biol. 2001;500:331-4. No abstract available.

PMID:
11764963
25.

Molecular requirements for inhibition of cytochrome p450 activities by roquefortine.

Aninat C, Hayashi Y, André F, Delaforge M.

Chem Res Toxicol. 2001 Sep;14(9):1259-65.

PMID:
11559041

Supplemental Content

Loading ...
Support Center